Subscribe to BIOTECanada’s news feed.
Click on “Follow” and decide if you want to get news from BIOTECanada via RSS, as email newsletter, via mobile or on your personal news page.
Subscription to BIOTECanada comes without risk as you can unsubscribe instantly at any time.
You can also filter the feed to your needs via topics and keywords so that you only receive the news from BIOTECanada which you are really interested in. Click on the blue “Filter” button below to get started.
Website title: Home - BIOTECanada
Is this your feed? Claim it!
MONTREAL–(BUSINESS WIRE)–Neurenati Therapeutics, a biotech company focused on the development of therapies for rare diseases, is pleased to appoint two highly-experienced members to its Board of Directors and Scientific and Clinical Advisory Board.
Dr. Daniel Guay is a seasoned e...
VENT-03 is the most advanced oral small-molecule cGAS inhibitor in clinical development
Trial designed to demonstrate proof-of-concept efficacy and safety in lupus as well as the potential of VENT-03 in additional I&I diseases, cardiometabolic conditions, and inflammaging
Top-line results expected in 2H 2026
WALTHAM...
MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS endometrial cancer, MSI-H and TMB-H cancers, in each case exceeding objective response rate (ORR) benchmarks in these difficult to treat populations In the monotherapy expansion cohorts, irrespective of tumor type, pa...
Celebrating the convergence of biology and technology and how it shapes our world
By Amal Zafar
This past fall, biotech leaders, scientists, government representatives, educators and science enthusiasts gathered across the country to participate in Global Biotech Week.
Spanning September 20 to 27 of this year, Global Biotech Week brought...
